Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K, Date: 2010-03-31
Original SEC Filing: Click here

---

Webplus: BSPM/20100331/10-K_1/1/000.htm SEC Original: biostar10k123109.htm
FORM 10-K x For the fiscal year ended December 31, 2009 OR o to For the transition period from 333-147363 BIOSTAR PHARMACEUTICALS, INC. Maryland 20-5101287 (State or other jurisdiction of incorporation or organization) (I.R.S. Employer Identification No.) No. 588 Shiji Xi Avenue Xianyang, Shaanxi Province The People’s Republic of China 712046 (Zip Code) 011-86-29-33686638 o þ þ o o þ

---

---

Webplus: BSPM/20100331/10-K_1/2_EX-10.27/000.htm SEC Original: ex10-27.htm
Wu Quan Mountain Land Use Transfer Agreement Party A: Village Committee of the Wu Quan Village, Jiang Cun Town, Hu County (Transferor) Party B: Shaanxi Aoxing Pharmaceutical Co., Ltd. (Transferee) I. Party A shall transfer the land use right to Party B of a land sized 9,000 Mou, east border at the center of Shi He, west border at the

---

---

Webplus: BSPM/20100331/10-K_1/3_EX-31.1/000.htm SEC Original: ex31-1.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Ronghua Wang, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: BSPM/20100331/10-K_1/4_EX-31.2/000.htm SEC Original: ex31-2.htm
SECTION 302 OF THE SARBANES-OXLEY ACT OF 2002 I, Elaine Zhao, certify that: 1. I have reviewed this annual report on Form 10-K of Biostar Pharmaceuticals, Inc.; 2. Based on my knowledge, this report does not contain any untrue statement of a material fact or omit to state a material fact necessary to make the statements made, in light of

---

---

Webplus: BSPM/20100331/10-K_1/5_EX-32.1/000.htm SEC Original: ex32-1.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Ronghua Wang Chief Executive Officer March 31, 2010 EX-32.1 5 ex32-1.htm

---

---

Webplus: BSPM/20100331/10-K_1/6_EX-32.2/000.htm SEC Original: ex32-2.htm
18 U.S.C. SECTION 1350, SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002 (2) The information contained in the Report fairly presents, in all material respects, the financial condition and result of operations of the Company at the dates and for the periods indicated. Elaine Zhao Chief Financial Officer March 31, 2010 EX-32.2 6 ex32-2.htm

---

Company Information:

Ticker: BSPM, Company: Biostar Pharmaceuticals, Inc., Type: 10-K, Date: 2010-03-31CIK: 0001418133, Location: F4, SIC: 2834, SIC Desc: PHARMACEUTICAL PREPARATIONS
Business Phone & Address:
NO. 588 SHIJI XI AVENUE
XIANYANG, SHAANXI PROVINCE 712046